Content Status

Type

Linked Node

H5Content
Content

Bedaquiline (Bdq) is a group A second line drug supplied as a jar containing 188 tablets having dosage strength of 100mg with 24 months of shelf life. The jar contains the dosages for entire 6 month of treatment duration.

Flow of Bedaquiline (Bdq) drug in NTEP

Figure: Flowchart depicting the drug flow of Bedaquiline

  • The Bdq drug is procured centrally and supplied to the Government Medical Store Depot (GMSD)/Central Medical Services Society (CMSS).
  • Based on  the report from the Ni-kshay Aushadhi, Central TB Division (CTD) prepares the Release Order (RO) following which the drugs are supplied to the respective State Drug Stores (SDS).
  • In case of Bedaquiline (Bdq), the drug is dispatched from the SDS to the Nodal/ District Drug-resistant TB Centre (N/DDR TBC) as the patients on Bdq are initiated on treatment at the N/DDR-TBC only.
  • Patients initiated on Bedaquiline (Bdq) treatment at the N/DDR-TBC are provided with the bottle containing Bdq during discharge which is then handed over to the treatment supporter under the supervision of the senior DR-TB/ TB-HIV supervisor.
  • Until the patient completes the Bdq treatment course, the bottle containing Bdq should be in the custody of the treatment supporter.
  • Once the bottle containing Bdq is issued to the patients/ treatment supporter at the N/DDR-TBC, their prescription should be uploaded on the Nikshay Aushadhi and the Senior DR-TB HIV supervisor should inform the storekeeper at the District Drug Store (DDS) about the same.
  • This information should also be entered into the stock register at the DDS, which will help the system to keep track of Bdq inventory.

 

Resources

 

Assessment

Question     Answer 1     Answer 2     Answer 3     Answer 4     Correct answer     Correct explanation     Page id     Part of Pre-test     Part of Post-test    
Bdq bottle is to be kept under the custody of the patient until the end of the course. True False     2 Bdq bottle is to be kept under the custody of the patient’s treatment supporter until the end of the course.   Yes Yes

Content Creator

Reviewer